This week, consumer magazines highlight hyperhidrosis, filler questions to ask a dermatologist, and more.
This week in aesthetics, we highlight baricitinib for hair regrowth in alopecia areata patients, the April “Meet the Aesthetic Expert” column, and more.
In this monthly technology review, Michael Kluska, DO, discusses Evolve by InMode, including device overview, cost, ROI, patient perceptions, and candidate considerations.
In this month’s "Meet the Aesthetic Expert" column, Will Kirby, DO, FAOCD, talks with dual board-certified dermatologist and dermatopathologist Amy Spizuoco, DO, FAOCD, FAAD, about her new role as president-elect of AOCD, the coveted millennial patient population, and how to leverage health and beauty for a more holistic approach to aesthetics.
A recent study in the Journal of Cosmetic Dermatology examines the safety and efficacy of using vitamin D intralesional injection for the treatment of keloid scars.
Eli Lilly and Incyte announce results from its phase 3 study evaluating baricitinib 2 mg and 4 mg for the treatment of alopecia areata, making it the first phase 3 study with top-line results in patients with the hair disorder.